$FGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIBROGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIBROGEN INC. Get notifications about new insider transactions in FIBROGEN INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 21 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.48 | 208 | 11,956 | 97,548 | 97.8 K to 97.5 K (-0.21 %) |
Sep 21 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 56.71 | 710 | 40,264 | 97,756 | 98.5 K to 97.8 K (-0.72 %) |
Sep 21 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.50 | 7,492 | 430,790 | 2,725,834 | 2.7 M to 2.7 M (-0.27 %) |
Sep 21 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 56.45 | 11,408 | 643,982 | 2,733,326 | 2.7 M to 2.7 M (-0.42 %) |
Sep 21 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,744,734 | 2.7 M to 2.7 M (+0.38 %) |
Sep 18 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 4,000 | 11,600 | 0 | |
Sep 18 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 59.41 | 1,200 | 71,292 | 23,700 | 24.9 K to 23.7 K (-4.82 %) |
Sep 18 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 58.63 | 2,800 | 164,164 | 24,900 | 27.7 K to 24.9 K (-10.11 %) |
Sep 18 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 4,000 | 11,600 | 27,700 | 23.7 K to 27.7 K (+16.88 %) |
Sep 14 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 2.90 | 10,500 | 30,450 | 29,500 | |
Sep 14 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 59.50 | 2,318 | 137,921 | 228,604 | 230.9 K to 228.6 K (-1.00 %) |
Sep 14 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 2.90 | 10,500 | 30,450 | 230,922 | 220.4 K to 230.9 K (+4.76 %) |
Sep 12 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 57.35 | 1,011 | 57,981 | 220,422 | 221.4 K to 220.4 K (-0.46 %) |
Sep 12 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 18.34 | 6,000 | 110,040 | 6,000 | |
Sep 12 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 57.60 | 1,700 | 97,920 | 131,540 | 133.2 K to 131.5 K (-1.28 %) |
Sep 12 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 57.19 | 4,300 | 245,917 | 133,240 | 137.5 K to 133.2 K (-3.13 %) |
Sep 12 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 18.34 | 6,000 | 110,040 | 137,540 | 131.5 K to 137.5 K (+4.56 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 227,021 | |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 237,341 | |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.30 | 200 | 11,460 | 98,466 | 98.7 K to 98.5 K (-0.20 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 56.58 | 718 | 40,624 | 98,666 | 99.4 K to 98.7 K (-0.72 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.44 | 3,405 | 195,583 | 2,734,414 | 2.7 M to 2.7 M (-0.12 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 56.60 | 15,495 | 877,017 | 2,737,819 | 2.8 M to 2.7 M (-0.56 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,753,314 | 2.7 M to 2.8 M (+0.38 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 59.08 | 200 | 11,816 | 99,384 | 99.6 K to 99.4 K (-0.20 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.66 | 718 | 41,400 | 99,584 | 100.3 K to 99.6 K (-0.72 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 59.77 | 3,600 | 215,172 | 2,742,994 | 2.7 M to 2.7 M (-0.13 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 58.85 | 2,820 | 165,957 | 2,746,594 | 2.7 M to 2.7 M (-0.10 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.73 | 12,480 | 720,470 | 2,749,414 | 2.8 M to 2.7 M (-0.45 %) |
Sep 07 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,761,894 | 2.8 M to 2.8 M (+0.38 %) |
Sep 06 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 57.30 | 2,368 | 135,686 | 150,907 | 153.3 K to 150.9 K (-1.54 %) |
Sep 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 57.30 | 6,373 | 365,173 | 2,751,574 | 2.8 M to 2.8 M (-0.23 %) |
Sep 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 61.05 | 2,286 | 139,560 | 2,757,947 | 2.8 M to 2.8 M (-0.08 %) |
Sep 06 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 57.30 | 2,277 | 130,472 | 221,433 | 223.7 K to 221.4 K (-1.02 %) |
Sep 06 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 61.05 | 994 | 60,684 | 223,710 | 224.7 K to 223.7 K (-0.44 %) |
Sep 05 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | M | 14.58 | 5,000 | 72,875 | 11,355 | |
Sep 05 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | M | 5.95 | 1,800 | 10,710 | 0 | |
Sep 05 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 61.05 | 994 | 60,684 | 153,275 | 154.3 K to 153.3 K (-0.64 %) |
Sep 05 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Buy | M | 14.58 | 5,000 | 72,875 | 154,269 | 149.3 K to 154.3 K (+3.35 %) |
Sep 05 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Buy | M | 5.95 | 1,800 | 10,710 | 149,269 | 147.5 K to 149.3 K (+1.22 %) |
Aug 24 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 19.05 | 12,000 | 228,600 | 0 | |
Aug 24 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Sell | S | 60.65 | 12,000 | 727,800 | 51,700 | 63.7 K to 51.7 K (-18.84 %) |
Aug 24 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 19.05 | 12,000 | 228,600 | 63,700 | 51.7 K to 63.7 K (+23.21 %) |
Aug 24 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 19.05 | 12,000 | 228,600 | 0 | |
Aug 24 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Sell | S | 60.65 | 12,000 | 727,800 | 51,700 | 63.7 K to 51.7 K (-18.84 %) |
Aug 24 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 19.05 | 12,000 | 228,600 | 63,700 | 51.7 K to 63.7 K (+23.21 %) |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 247,661 | |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 257,981 | |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 60.59 | 918 | 55,622 | 100,302 | 101.2 K to 100.3 K (-0.91 %) |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 60.71 | 14,535 | 882,420 | 2,760,233 | 2.8 M to 2.8 M (-0.52 %) |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 60.00 | 4,365 | 261,900 | 2,774,768 | 2.8 M to 2.8 M (-0.16 %) |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,779,133 | 2.8 M to 2.8 M (+0.37 %) |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 59.82 | 918 | 54,915 | 101,220 | 102.1 K to 101.2 K (-0.90 %) |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 60.36 | 4,003 | 241,621 | 2,768,813 | 2.8 M to 2.8 M (-0.14 %) |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 59.83 | 14,897 | 891,288 | 2,772,816 | 2.8 M to 2.8 M (-0.53 %) |
Aug 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,787,713 | 2.8 M to 2.8 M (+0.37 %) |
Aug 17 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 4,000 | |
Aug 17 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 60.64 | 580 | 35,171 | 32,700 | 33.3 K to 32.7 K (-1.74 %) |
Aug 17 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 59.78 | 420 | 25,108 | 33,280 | 33.7 K to 33.3 K (-1.25 %) |
Aug 17 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 33,700 | 32.7 K to 33.7 K (+3.06 %) |
Aug 17 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 4,000 | 11,600 | 4,000 | |
Aug 17 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 60.65 | 2,450 | 148,593 | 23,700 | 26.2 K to 23.7 K (-9.37 %) |
Aug 17 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 59.70 | 1,550 | 92,535 | 26,150 | 27.7 K to 26.2 K (-5.60 %) |
Aug 17 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 4,000 | 11,600 | 27,700 | 23.7 K to 27.7 K (+16.88 %) |
Aug 10 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 18.00 | 6,000 | 108,000 | 0 | |
Aug 10 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 61.21 | 272 | 16,649 | 131,540 | 131.8 K to 131.5 K (-0.21 %) |
Aug 10 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 60.36 | 2,028 | 122,410 | 131,812 | 133.8 K to 131.8 K (-1.52 %) |
Aug 10 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 59.60 | 3,700 | 220,520 | 133,840 | 137.5 K to 133.8 K (-2.69 %) |
Aug 10 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 18.00 | 6,000 | 108,000 | 137,540 | 131.5 K to 137.5 K (+4.56 %) |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 268,301 | |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 278,621 | |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 62.88 | 918 | 57,724 | 102,138 | 103.1 K to 102.1 K (-0.89 %) |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.19 | 7,300 | 461,287 | 2,777,393 | 2.8 M to 2.8 M (-0.26 %) |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 62.71 | 11,600 | 727,436 | 2,784,693 | 2.8 M to 2.8 M (-0.41 %) |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,796,293 | 2.8 M to 2.8 M (+0.37 %) |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.08 | 918 | 57,907 | 103,056 | 104 K to 103.1 K (-0.88 %) |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.54 | 5,240 | 332,950 | 2,785,973 | 2.8 M to 2.8 M (-0.19 %) |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 62.95 | 13,660 | 859,897 | 2,791,213 | 2.8 M to 2.8 M (-0.49 %) |
Aug 03 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,804,873 | 2.8 M to 2.8 M (+0.37 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 5,000 | |
Jul 20 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 64.90 | 1,000 | 64,900 | 32,700 | 33.7 K to 32.7 K (-2.97 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 33,700 | 32.7 K to 33.7 K (+3.06 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 288,941 | |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 299,261 | |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.27 | 918 | 59,000 | 103,974 | 104.9 K to 104 K (-0.88 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.80 | 100 | 6,480 | 2,794,553 | 2.8 M to 2.8 M (0.00 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.34 | 18,800 | 1,209,592 | 2,794,653 | 2.8 M to 2.8 M (-0.67 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,813,453 | 2.8 M to 2.8 M (+0.37 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 65.48 | 918 | 60,111 | 104,892 | 105.8 K to 104.9 K (-0.87 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 65.70 | 10,800 | 709,560 | 2,803,133 | 2.8 M to 2.8 M (-0.38 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 65.19 | 8,100 | 528,039 | 2,813,933 | 2.8 M to 2.8 M (-0.29 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,822,033 | 2.8 M to 2.8 M (+0.37 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 4,000 | 11,600 | 0 | |
Jul 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 64.35 | 4,000 | 257,400 | 23,700 | 27.7 K to 23.7 K (-14.44 %) |
Jul 20 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 4,000 | 11,600 | 27,700 | 23.7 K to 27.7 K (+16.88 %) |
Jul 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 18.00 | 6,000 | 108,000 | 6,000 | |
Jul 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 67.71 | 6,000 | 406,260 | 131,540 | 137.5 K to 131.5 K (-4.36 %) |
Jul 11 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 18.00 | 6,000 | 108,000 | 137,540 | 131.5 K to 137.5 K (+4.56 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | M | 14.58 | 15,645 | 228,026 | 16,355 | |
Jul 06 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 65.00 | 15,645 | 1,016,925 | 147,469 | 163.1 K to 147.5 K (-9.59 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Buy | M | 14.58 | 15,645 | 228,026 | 163,114 | 147.5 K to 163.1 K (+10.61 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | M | 2.90 | 7,639 | 22,153 | 12,000 | |
Jul 06 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Sell | S | 65.00 | 7,639 | 496,535 | 3,700 | 11.3 K to 3.7 K (-67.37 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Buy | M | 2.90 | 7,639 | 22,153 | 11,339 | 3.7 K to 11.3 K (+206.46 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 309,581 | |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 319,901 | |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 66.80 | 318 | 21,242 | 105,810 | 106.1 K to 105.8 K (-0.30 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 65.61 | 600 | 39,366 | 106,128 | 106.7 K to 106.1 K (-0.56 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 66.96 | 2,637 | 176,574 | 2,811,713 | 2.8 M to 2.8 M (-0.09 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 66.16 | 8,723 | 577,114 | 2,814,350 | 2.8 M to 2.8 M (-0.31 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 65.24 | 5,940 | 387,526 | 2,823,073 | 2.8 M to 2.8 M (-0.21 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.15 | 1,600 | 102,640 | 2,829,013 | 2.8 M to 2.8 M (-0.06 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,830,613 | 2.8 M to 2.8 M (+0.37 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.75 | 100 | 6,475 | 106,728 | 106.8 K to 106.7 K (-0.09 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.92 | 818 | 52,287 | 106,828 | 107.6 K to 106.8 K (-0.76 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.62 | 5,400 | 348,948 | 2,820,293 | 2.8 M to 2.8 M (-0.19 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.97 | 13,500 | 863,595 | 2,825,693 | 2.8 M to 2.8 M (-0.48 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,839,193 | 2.8 M to 2.8 M (+0.36 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | M | 14.58 | 15,645 | 228,026 | 16,355 | |
Jul 06 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 65.00 | 15,645 | 1,016,925 | 147,469 | 163.1 K to 147.5 K (-9.59 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Buy | M | 14.58 | 15,645 | 228,026 | 163,114 | 147.5 K to 163.1 K (+10.61 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | M | 2.90 | 7,639 | 22,153 | 12,000 | |
Jul 06 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Sell | S | 65.00 | 7,639 | 496,535 | 3,700 | 11.3 K to 3.7 K (-67.37 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Buy | M | 2.90 | 7,639 | 22,153 | 11,339 | 3.7 K to 11.3 K (+206.46 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 309,581 | |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 319,901 | |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 66.80 | 318 | 21,242 | 105,810 | 106.1 K to 105.8 K (-0.30 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 65.61 | 600 | 39,366 | 106,128 | 106.7 K to 106.1 K (-0.56 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 66.96 | 2,637 | 176,574 | 2,811,713 | 2.8 M to 2.8 M (-0.09 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 66.16 | 8,723 | 577,114 | 2,814,350 | 2.8 M to 2.8 M (-0.31 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 65.24 | 5,940 | 387,526 | 2,823,073 | 2.8 M to 2.8 M (-0.21 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.15 | 1,600 | 102,640 | 2,829,013 | 2.8 M to 2.8 M (-0.06 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,830,613 | 2.8 M to 2.8 M (+0.37 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.75 | 100 | 6,475 | 106,728 | 106.8 K to 106.7 K (-0.09 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.92 | 818 | 52,287 | 106,828 | 107.6 K to 106.8 K (-0.76 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.62 | 5,400 | 348,948 | 2,820,293 | 2.8 M to 2.8 M (-0.19 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.97 | 13,500 | 863,595 | 2,825,693 | 2.8 M to 2.8 M (-0.48 %) |
Jul 06 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,839,193 | 2.8 M to 2.8 M (+0.36 %) |
Jun 26 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | M | 2.90 | 4,361 | 12,647 | 19,639 | |
Jun 26 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Sell | S | 65.00 | 4,361 | 283,465 | 3,700 | 8.1 K to 3.7 K (-54.10 %) |
Jun 26 2018 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Buy | M | 2.90 | 4,361 | 12,647 | 8,061 | 3.7 K to 8.1 K (+117.86 %) |
Jun 22 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 6,000 | |
Jun 22 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 63.65 | 1,000 | 63,650 | 32,700 | 33.7 K to 32.7 K (-2.97 %) |
Jun 22 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 33,700 | 32.7 K to 33.7 K (+3.06 %) |
Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 330,221 | |
Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 10,320 | 37,152 | 340,541 | |
Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.60 | 918 | 58,385 | 107,646 | 108.6 K to 107.6 K (-0.85 %) |
Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 64.08 | 3,728 | 238,890 | 2,828,873 | 2.8 M to 2.8 M (-0.13 %) |
Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 63.54 | 15,172 | 964,029 | 2,832,601 | 2.8 M to 2.8 M (-0.53 %) |
Jun 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 10,320 | 37,152 | 2,847,773 | 2.8 M to 2.8 M (+0.36 %) |